Clene, Inc. (CLNN)
7.24
-0.15
(-2.03%)
USD |
NASDAQ |
May 08, 16:00
7.295
+0.06
(+0.76%)
After-Hours: 20:00
Clene EPS Diluted (Quarterly) : -0.8801 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Precigen, Inc. | -0.0664 |
| Plus Therapeutics, Inc. | -1.03 |
| Perspective Therapeutics, Inc. | -0.5043 |
| AVITA Medical, Inc. | -0.3825 |
| Harvard Apparatus Regenerative Technology, Inc. | -0.0979 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -9.226M |
| Revenue (Quarterly) | 0.077M |
| Total Expenses (Quarterly) | 9.303M |
| Enterprise Value | 103.53M |
| Gross Profit Margin (Quarterly) | -397.4% |
| Profit Margin (Quarterly) | -11.98K% |
| Earnings Yield | -35.88% |
| Normalized Earnings Yield | -35.83 |